Tale of two drugs Two of these GLP-1 receptor agonists are FDA-approved in formulations specifically designed for weight loss in people without diabetes: liraglutide (Saxenda) and semaglutide (Wegovy)
Jacob Tangir, with The Center for Gynecologic Oncology in Miramar, said while studies are in early stages, the data on GLP-1 and endometrial cancer are encouraging
Individuals with a Focus On Preventive Health Even if you do not have type 2 diabetes or other specific health conditions, you may still benefit from exploring GLP-1 shots from BodyLogicMD if you are interested in preventive health
FDA approves first medication for obstructive sleep apnea
No, but I will show you how to make it a better choice
The first few days I only did a single spray, then after a few days increased to 2 sprays which works out to roughly 80mcg nasal spray dosage and would typically dose 45 minutes before exposing myself to sunlight